Barclays analyst Lauren Lieberman raised the firm’s price target on Keurig Dr Pepper (KDP) to $30 from $26 and keeps an Equal Weight rating on the shares following the investor day. The company’s updates around financing and post-separation capital structure proved more constructive than expected, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Balanced Hold Rating on Keurig Dr Pepper Amid Strategic Moves and Investment Complexities
- Keurig Dr Pepper price target raised to $35 from $33 at Wells Fargo
- Keurig Dr Pepper’s Strong Q3 Performance and Strategic Moves Justify Buy Rating
- Keurig Dr Pepper’s Strong Performance and Strategic Investments Justify Buy Rating
- Keurig Dr Pepper Reports Strong Q3 2025 Results